DNLI

18.4401.32%
CW

Chris Walsh

General Counsel

Mr. Chris Walsh serves as General Counsel at Denali Therapeutics Inc. since November 2022 and was its Associate General Counsel since September 2020 until November 2022 and has served as its Vice President of Legal since 2019 until September 2020.

Positions